4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†. Read more about 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Read more about A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors.
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis. Read more about Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. Read more about Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial.
Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis. Read more about Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis.
Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Read more about Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer.
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Read more about 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance. Read more about Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance.
International cancer seminars: a focus on esophageal squamous cell carcinoma. Read more about International cancer seminars: a focus on esophageal squamous cell carcinoma.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Read more about Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
